earn	coopervision eye delays annual meeting coopervision inc delayed annual meeting june board review recapitalization options meeting coopervision today reported quarter net income mln dlrs mln dlr pretax gain sale ophthalmic business johnson and johnson jnj for mln dlrs cash and mln dlr posttax charge debt repurchase sales mln dlrs year earlier earned dlrs dlr loss discontinued operations sales mln dlrs company aggressive program investment spending maintain increase market shares two core businesses will accelerate sales growth this year hold back increases operating income future coopervision entire net cash proceeds recent sales businesses employed reduce indebtedness make strategic acquisitions and employed relation recapitalization company recovery net income will held back loss tax income ophthalmic pharmaceutical business sold johnson and johnson InformationRetrieval.reuter